4//SEC Filing
DEXCOM INC 4
Accession 0001093557-17-000029
$DXCMCIK 0001093557operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:19 PM ET
Size
8.8 KB
Accession
0001093557-17-000029
Insider Transaction Report
Form 4
DEXCOM INCDXCM
LISTER JOHN
VP, Legal Affairs
Transactions
- Exercise/Conversion
Common Stock
2017-02-09$8.85/sh+3,000$26,550→ 73,598 total - Sale
Common Stock
2017-02-09$79.73/sh−3,000$239,204→ 70,598 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2017-02-09$79.73/sh−3,000$239,204→ 13,939 totalExercise: $8.85From: 2009-01-14Exp: 2018-01-14→ Common Stock (3,000 underlying)
Footnotes (3)
- [F1]On December 13, 2016, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $79.41 to $80.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Included in this number are 61,584 unvested restricted stock units, 32,000 of which were granted on June 30, 2016 and shall vest through March 8, 2019, 18,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 10,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093557
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 7:19 PM ET
- Size
- 8.8 KB